Scientists have identified 16 genes that breast cancer cells use to survive in the bloodstream after they've escaped the low-oxygen regions of a tumor. Each is a potential therapeutic target to stop ...

Following her two decades at biotechnology companies Amgen and Genentech, Slatter was elected in 2015 to the Bellevue City Council, and then appointed to the Legislature in 2017. She chairs the ...

At study sites in Seattle, San Diego, and Birmingham ... Research to Prevent Blindness; personal fees — Genentech, Sanofi, US FDA, Johnson and Johnson, Boehringer Ingelheim, Gyroscope; non-financial ...

Scientists at the Johns Hopkins Kimmel Cancer Center have identified 16 genes that breast cancer cells use to survive in the bloodstream after they've escaped the low-oxygen regions of a tumor.

Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The long-term risk of distant recurrence for women with ...

Seattle Genetics is working with Genentech (who recently extended their ADC development deal with them), Millennium Pharmaceuticals, GlaxoSmithKline, Celldex Therapeutics, Progenics ...

She completed her postdoctoral training at Genentech under the mentorship of Dr. Ira Mellman ... non-invasively monitor immune cell interactions within tumors. Kate joined Seattle Children’s Research ...

Ms. Patel joins from Roche/Genentech, where she led the successful launch of Hemlibra ... Bristol Myers Squibb, Takeda Ventures, Seattle Children’s Research Institute and others to re-imagine medicine ...

As Election Day 2024 gets closer, STAT’s First Opinion asked executives from leading biotech and pharmaceutical companies to reflect on how their industry is being portrayed in the presidential ...

Aviv Regev, executive vice president and head of Genentech Research & Early Development (gRED) NVIDIA’s push into the life sciences sector has been rewarded by a wide-ranging deal with Roche’s ...

Roche’s Genentech unit signed a trio of deals this week to add new drug discovery platforms to its repertoire. The three drug discovery deals are with Convelo Therapeutics in neurological ...